Evolution of Symptoms After Anterior Sacrospinofixation by Autologous Tissues

NCT04270188 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2026-03-06

No results posted yet for this study

Summary

Prolapse is a pathology that can cause pelvic, urinary or sexual functional disorders and impaired quality of life. Although the use of vaginal mesh is a commonly practiced technique to correct prolapse, in recent years health officials have pointed to the lack of adequate safety and tolerability assessments of these implants. Currently, surgeons are therefore moving towards techniques without implants. The standard vaginal technique for the treatment of uterine prolapse is sacrospinofixation according to Richter. This technique can be performed without an implant, using autologous tissue.

Functional discomfort of patients is the main problem linked to the presence of prolapse. However, no study has yet evaluated the feelings of patients following the use of this sacrospinofixation technique by autologous tissues by vaginal route, which led us to set up this study.

The hypothesis is that the technique of anterior sacrospinofixation by autologous tissues improves the symptoms experienced by patients with an mid-level and / or anterior genital prolapse.

Conditions

  • Pelvic Organ Prolapse

Interventions

OTHER

evolution of patient symptoms

evolution of symptoms on the PGI-I scale (score 1, 2, or 3) 2 months after surgery

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Principal Investigators

  • Géry LAMBLIN, MD · Hospices Civils de Lyon

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-21
Primary Completion
2025-10-28
Completion
2025-10-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04270188 on ClinicalTrials.gov